Sign Up
OverviewAPI
The global oncology drugs market is poised to expand at an impressive CAGR of 11.53%, reaching $474.06 billion by 2030, fueled by factors like the growing cancer incidence and pharmaceutical advancements. Major players such as Bristol Myer Squibb, GlaxoSmithKline, and Biocon Biologics are intensifying R&D efforts and engaging in significant mergers and acquisitions. Targeted therapy, particularly in injectable forms, dominates the market segmented by various categories.

Ask a question